🇺🇸 FDA
Patent

US 6696242

Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6696242 (Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61K39/00, A61P, A61P1/16